Retour aux projets

19310.1 PFLS-LS

19310.1 PFLS-LS

Résumé

Discovery & development of novel peptide drug conjugates for the treatment of acute myeloid leukemia

Textes supplémentaires

Abstract

To develop novel peptide drug conjugates that target a newly identified cancer marker overexpressed in multiple cancers. The project aims to create peptide drug conjugates for treating acute myeloid leukemia and obtain at least one drug candidate ready for further development. This will enable Phi Pharma to secure additional financing to prepare for the first clinical trial, and eventually enter into a significant collaboration with a major pharmaceutical company.

Participants

Emmanuel Savioz

Wirtschaftspartner

emmanuel.savioz@phi-pharma.com

Phi Pharma Emmanuel Savioz Place du Midi 36 1950 Sion VS CH

Marc Mathieu

Kontaktperson

marc.mathieu@hevs.ch

HES-SO Valais-Wallis Marc Mathieu Route du Rawyl 64 1950 Sion VS CH

Détails du projet

Office de recherche
INNOSUISSE
Statut du projet
Abgeschlossen
Type de projet
Forschungsprojekt
Date de début
2016-09-30
Date de fin
2018-04-30
Coûts totaux approuvés
CHF 357830.00
Section
20 Förderbereich Life Sciences
Domaine politique NABS
Industrielle Produktivität und Technologie

Disciplines de recherche

  • T490 Biotechnology 100.0%